Amid drug shortages, could cannabis lessen the burden?
If COVID-19 has made anything clear, it’s the precarious position of many vital global supply chains. One of the most alarming issues is the risk to pharmaceutical production networks. Last month China’s manufacturing and production ground to a halt as the country went into lockdown to contain the virus. This shutdown had an immediate impact on industries around the world, including pharmaceutical ingredients.